| Announce Date | 06/30/2020 |
| EPS Normalized Actual | $-0.0739 (Miss by $-10.8939) |
| EPS GAAP Actual | $-0.0739 (Miss by $-10.8939) |
| Revenue Actual | $0.0447975B |
| Revenue Surprise | Beat by $44.7975M |
| Announce Date | 01/09/2026 (Pre-Market) |
| EPS Normalized Estimate | $10.8184 |
| EPS GAAP Estimate | $10.8184 |
| Revenue Estimate | $0.035966B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 261.987 | 0.01 | 261.987 | 261.987 | 1 |
| Dec 2027 | -120.67874 | -0.01 | -120.67874 | -120.67874 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | -1 | -11.8184 | 0.0447975B | 32.46% | 8.83M |
| FQ2 2025 (Jun 2025) | -1 | 0.29948 | 0.0447975B | 32.46% | 13.3M |
| FQ3 2024 (Sep 2024) | -0.37 | -1.91141 | 0.085455B | 100% | -1151.54M |
| FQ4 2024 (Dec 2024) | -0.37 | -1.09123 | 0.085455B | 100% | 49.49M |
| FQ1 2024 (Mar 2024) | -0.15 | -1.72645 | 0.030257B | 100% | -1041.81M |
| FQ2 2024 (Jun 2024) | -0.15 | -1.49259 | 0.030257B | 100% | -1124.27M |
| FQ1 2019 (Mar 2019) | 0 | 0 | 3.7E-5B | 100% | 0.04M |
| FQ1 2020 (Mar 2020) | 0 | 0 | 0.0049545B | 99.25% | 4.95M |
FQ4 Announce Date
01/09/2026 (Pre-Market)
Consensus EPS Estimates
10.8184
Consensus Revenue Estimates
0.035966B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
5
EPS # of in-lines
2
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | 10.8184 | -1 | -11.8184 | 1181.84% |
| FQ2 2025 (Jun 2025) | -1.29948 | -1 | 0.29948 | -29.95% |
| FQ3 2024 (Sep 2024) | 1.54141 | -0.37 | -1.91141 | 516.6% |
| FQ4 2024 (Dec 2024) | 0.72123 | -0.37 | -1.09123 | 294.93% |
| FQ1 2024 (Mar 2024) | 1.57645 | -0.15 | -1.72645 | 1150.97% |
| FQ2 2024 (Jun 2024) | 1.34259 | -0.15 | -1.49259 | 995.06% |
| FQ1 2019 (Mar 2019) | 0 | 0 | NAN% | |
| FQ1 2020 (Mar 2020) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | $0.04B | $0.04B | $8.83M | 19.71% |
| FQ2 2025 (Jun 2025) | $0.03B | $0.04B | $13.3M | 29.69% |
| FQ3 2024 (Sep 2024) | $1.24B | $0.09B | $-1151.54M | -1347.54% |
| FQ4 2024 (Dec 2024) | $0.04B | $0.09B | $49.49M | 57.91% |
| FQ1 2024 (Mar 2024) | $1.07B | $0.03B | $-1041.81M | -3443.19% |
| FQ2 2024 (Jun 2024) | $1.15B | $0.03B | $-1124.27M | -3715.74% |
| FQ1 2019 (Mar 2019) | $0B | $0B | $0.04M | 100% |
| FQ1 2020 (Mar 2020) | $0B | $0B | $4.95M | 100% |